Your browser doesn't support javascript.
loading
Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19.
Parvizi, Mohammad Mahdi; Forouhari, Sedigheh; Shahriarirad, Reza; Shahriarirad, Sepehr; Bradley, Ryan D; Roosta, Leila.
Afiliación
  • Parvizi MM; Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. mmparvizi@gmail.com.
  • Forouhari S; Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. mmparvizi@gmail.com.
  • Shahriarirad R; Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Shahriarirad S; Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. r.shahriari1995@gmail.com.
  • Bradley RD; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. r.shahriari1995@gmail.com.
  • Roosta L; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
BMC Complement Med Ther ; 22(1): 251, 2022 Sep 30.
Article en En | MEDLINE | ID: mdl-36180868
BACKGROUND: Complementary and Integrative Medicine (CIM) is often taken up by individuals seeking relief from different diseases. This study investigates the prevalence and associated factors of CIM use in patients with COVID-19. METHODS: In this telephone-based, cross-sectional study, data on CIM usage were collected from COVID-19 patients from February till June 2020 in Fars province, Iran using a researcher-made checklist. Additionally, we asked about the patients' attitudes toward these treatments. RESULTS: Out of 453 patients diagnosed with COVID-19, 400 (88.30%) responded to our calls and agreed to participate in the study. Among them, 276 patients reported using CIM to treat COVID-19 [prevalence: 69% (95% CI: 64.2 to 73.5)]. The most frequently used herbal medicine among COVID-19 patients was ginger (n = 273, 98.9%), thyme (n = 263, 95.3%), and black cumin (n = 205, 74.3%). Most of these patients were recommended to use herbal medicine by their families and friends (n = 96, 34.8%). Univariable logistic regression revealed that age under 50 years old, residency in urban areas (including the capital of the province and small cities), employment, academic education, and being an outpatient were statistically significant factors resulting in CIM usage. Multivariable logistic regression revealed that CIM use among outpatients was 3.65 times more than among inpatients. In addition, patients under 50 years old used CIM 85% more than older patients. Ultimately, only 9 (3.3%) patients consulted with their doctors regarding these medications. No side effects due to CIM use were reported. CONCLUSION: Many patients with COVID-19 used CIM, but few consulted with their physicians in this regard. Therefore, physicians should ask their patients about CIM usage, and patients should also report their use of CIM therapies during their medical visits. Furthermore, age and hospitalization status affected CIM use among patients with COVID-19.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapias Complementarias / Medicina Integrativa / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: BMC Complement Med Ther Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapias Complementarias / Medicina Integrativa / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: BMC Complement Med Ther Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido